Does valganciclovir reduce T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy?
CMV (and/or other herpesvirus) replication is a significant cause of immune activation in HIV-infected individuals with incomplete antiretroviral therapy-mediated CD4(+) T cell recovery.
Women with the IVS1-401 T allele of the ER-alpha and/or factor V Leiden are at increased risk for late fetal loss.